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A major challenge in proteomics is the absolute accurate
quantification of large numbers of proteins. QconCATs,
artificial proteins that are concatenations of multiple
standard peptides, are well established as an efficient
means to generate standards for proteome quantification.
Previously, QconCATs have been expressed in bacteria,
but we now describe QconCAT expression in a robust,
cell-free system. The new expression approach rescues
QconCATs that previously were unable to be expressed
in bacteria and can reduce the incidence of proteolytic
damage to QconCATs. Moreover, it is possible to cosyn-
thesize QconCATs in a highly-multiplexed translation
reaction, coexpressing tens or hundreds of QconCATs
simultaneously. By obviating bacterial culture and
through the gain of high level multiplexing, it is now pos-
sible to generate tens of thousands of standard peptides
in a matter of weeks, rendering absolute quantification of
a complex proteome highly achievable in a reproducible,
broadly deployable system. Molecular & Cellular Pro-
teomics 16: 10.1074/mcp.RA117.000284, 2169–2183, 2017.
One of the major challenges in proteomics is absolute
quantification of individual proteins. The predominant tech-
nology in large scale protein quantification is MS of (usually
tryptic) peptides derived from proteolysis of the proteome in
vitro and it is well understood that although mass spectrom-
eters can deliver linearity of response over many orders of
magnitude, the response factor (signal intensity per mol of
peptide) varies considerably among individual peptides (1, 2).
One outcome is that commonly used “label-free” methods
that sum the precursor ion intensities for the peptides derived
from a single protein, are excellent for relative quantification,
but are less satisfactory for absolute quantification.
MS-based absolute quantification of proteins can be sup-
ported by external standards that are analyzed before and/or
after the analyte or by stable-isotope labeled internal stand-
ards that are coanalyzed and which define the response factor
for each peptide (3). These peptides can be individually syn-
thesized and quantified (4) and there have been some remark-
able large-scale studies. However, large numbers of accu-
rately quantified peptides are costly. Further, a commercially
produced, accurately quantified standard peptide is a finite
resource and is hence best focused on low numbers of assays
of a small number of target proteins. Intact protein standards
(5–7), or large fragments (8) provide multiple potential pep-
tides for quantification of the targets.
In 2005, a novel approach to the creation of standard pep-
tides by biosynthesis was proposed in the form of QconCATs
(9–13). QconCATs are artificial proteins that are concatena-
tions of standard peptides from multiple natural proteins,
sometimes interspersed by short peptides to recapitulate the
primary sequence context of the natural counterpart (14, 15).
Peptides suitable for quantification are referred to as Q-pep-
tides, and are not synonymous with proteotypic peptides, as
the latter term refers to peptides, unique to one protein, that
drive protein identification, not quantification. QconCATs
genes are synthesized de novo and are routinely expressed in
E. coli cultured in media supplemented with appropriate sta-
ble isotope labeled amino acids, such that peptides derived
from QconCATs are discriminable from natural peptides
within the mass spectrometer. The purified QconCATs are
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mixed with the biological analyte sample and coproteolyzed
to generate a mixture of labeled (standard) and unlabeled
(analyte) peptide pairs that can be analyzed by liquid chroma-
tography coupled to MS to yield absolute quantification of the
analyte proteins. QconCATs have the added advantage that
with appropriate control of proteolysis (11) all standards are,
by definition, in a 1:1 ratio, rendering independent quantifica-
tion of each standard unnecessary; a single common peptide
can function to quantify the QconCAT (13). However, suc-
cessful expression of novel QconCATs in E. coli is not always
guaranteed. In a large-scale quantification project that used
over 100 independently designed and expressed QconCATs,
we discovered that 1 in 10 of the concatamers would fail to
express, even when a range of expression conditions were
explored. Further, at a low frequency, some QconCATs were
prone to proteolysis in the bacterial cell or during purification,
rendering them of reduced value for quantification.
Effective QconCAT deployment across large scale pro-
teome quantification studies would require a high level of
confidence in expression of every new construct. In addition,
living-cell based synthesis systems are not ideal for high-
throughput preparation of multiple QconCATs and many
mass spectrometry laboratories are not equipped for the ba-
sic molecular biology that would be needed to subclone and
express recombinant proteins. To enhance the potential of
QconCAT technology for large-scale proteome quantification,
we here focus on a wheat germ cell-free protein synthesis
system (WGCFS)1 as a major enhancement to the workflow of
high throughput QconCAT synthesis. WGCFS, which uses the
powerful translation system for germination stored in wheat
germ, realizes the highest yield of translation among commer-
cially available eukaryotic derived cell-free systems (16–20).
Using WGCFS, we previously demonstrated the feasibility of
synthesis of single, small QconCATs, typically 25 kDa (21). In
the present study, we first assessed whether WGCFS could
be used to express more typical QconCATs at approx. 60 kDa
(for quantification of 25 proteins at two peptides per target
protein), whether WGCFS would rescue “failed” QconCATs
and whether this cell free system was able to reduce the risk
of proteolytic degradation. Further, we established whether
an additional step in efficiency could be derived from coex-
pression of multiple QconCATs in a single WGCFS reaction.
EXPERIMENTAL PROCEDURES
Subcloning of QconCAT Genes—From the QconCAT gene library
based on plasmid vector pET21a (University of Liverpool) (13), twelve
QconCATs (one that expressed well: CC# 001, and eleven that had
failed to express: CC# 024, 039, 046, 057, 062, 064, 066, 068, 069,
099, and 103) were selected for subcloning into the cell-free expres-
sion vector pEU-E01-MCS (CellFree Sciences, Matsuyama, Japan).
Target QconCAT gene was amplified by PCR using a sense primer
(5-ATATACATATGGCAGGTCGTG-3) and an antisense primer (5-
CCGGGATCCCCATCATTAGTG-3). The obtained PCR products
were ligated with the EcoRV and BamHI sites of the pEU-E01-MCS.
The ligation products were then transformed into the E. coli DH5.
After overnight culture in LB medium containing 50 g/ml ampicillin,
plasmid DNA was purified with the alkaline lysis method. Correct
insertion of the QconCAT genes into the pEU-E01-MCS was verified
by DNA sequencing.
DNA Template Preparation for In Vitro Transcription Using PCR—
PCR-based cell-free expression templates were prepared using a
split-primer PCR method (18). The first PCR amplification was per-
formed using a sense primer (5-CCACCCACCACCACCAATGGC[A/
C/G/T]GG[C/T]CGTGA[A/G]GG[C/T]G-3) and an antisense primer
(5-CTTTTCTACGGGGTCTGACG-3). In the second PCR amplification,
following primers were used: SPu primer (5-GCGTAGCATTTAGGT-
GACACTATAGAAC-3), deSP6E01 primer (5-GGTGACACTATAG-A-
ACTCACCTATCTCCCCAACACCTAATAACATTCAATCACTCTTTCC-
ACTAACCACCTATCTACATCACCACCCACCACCACCAATG-3), and
the antisense primer. The second PCR products were purified with
ethanol precipitation and resolubilized with nuclease-free water. The
quality of PCR generated template was assessed by agarose gel
electrophoresis. DNA concentrations were determined using Qubit®
DNA Assay Kits (Life Technologies, Carlsbad, CA, USA) according to
the manufacturer’s instructions.
Cell-free Synthesis of Stable Isotope Labeled QconCATs—For cell-
free synthesis of QconCATs, we used the WEPRO 8240 H (K; 13C,15N,
R; 13C,15N) Expression kit (Kit No. 10FX01–12B03) from Cell Free
Sciences, Matsuyama, Japan. In the wheat germ cell-free synthesis
experiment, transcription and translation reaction are performed in-
dependently (22) and the mRNA used for cell-free synthesis was
prepared by in vitro transcription reaction using SP6 RNA
polymerase for 6 h at 37 °C. Translation in vitro of heavy-labeled
QconCAT proteins, using the bilayer method (20, 21), was for 20 h at
16 °C. In small-scale synthesis experiments, 200 l substrate layer
and 40 l translation layer were prepared in a 96-well microplate. In
large-scale cosynthesis experiments, translation in vitro was in a
6-well microplate (1 ml translation layer and 5 ml substrate layer) or a
12-well microplate (0.2 ml translation layer and 1 ml substrate layer).
For high efficiency stable-isotope labeling, [13C6,
15N4]Arg and
[13C6,
15N2]Lys (Wako, Osaka, Japan) were added to the translation
layer (final concentration of 20 mM each). The detailed procedures are
shown in supplemental Fig. S1.
Purification of Synthesized QconCAT Proteins—After completion of
cell-free synthesis, 200 l of the crude cell-free reaction mixture was
diluted with an equal volume of binding buffer (20 mM sodium phos-
phate, 0.5 M NaCl, 10 mM imidazole, pH 7.4) and incubated with 10 l
of Ni-Sepharose High Performance resin (GE Healthcare, Pittsburgh,
PA, USA) on a rolling wheel for 1 h at room temperature. The resin was
washed twice with 400 l of wash buffer (20 mM sodium phosphate,
0.5 M NaCl, 50 mM imidazole, pH 7.4). Binding proteins were eluted
with 30 l of an elution buffer (20 mM sodium phosphate, 0.5 M NaCl,
500 mM imidazole, pH 7.4).
Tryptic Digestion of Gel-separated QconCATs—Synthesized and
purified QconCAT proteins were separated on a NuPAGE 4–12%
Bis-Tris gel (Life Technologies), and stained using Bio-Safe CBB
(Bio-Rad, Hercules, CA). Protein bands were excised from the gel,
and each gel piece was destained using 50% (v/v) acetonitrile in 100
mM ammonium bicarbonate. After washing with 100 mM ammonium
bicarbonate, proteins were reduced with 10 mM dithiothreitol for 1.5 h
at 37 °C, and subsequently alkylated with 50 mM acrylamide for 30
min at room temperature. Proteins in the gel were digested with
sequencing-grade modified trypsin (Promega, Madison, WI) at 37 °C
overnight.
1 The abbreviations used are: WGCFS, wheat germ cell-free syn-
thesis system; DDA, data directed acquisition; SRM, selected reac-
tion monitoring; FP, fibrinopeptide; MS/MS, Tandem MS; LC-MS,
liquid chromatography-mass spectrometry.
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Mass Spectrometry—Tandem MS (MS/MS) and selected reaction
monitoring (SRM) was on an Eksigent nanoLC system connected to a
Q-Trap 5500 mass spectrometer (SCIEX, Framingham, MA, USA) as
described previously (21). The digested peptide samples were in-
jected onto a 200 m ID  0.5 mm cHiPLC trap column (SCIEX).
Concentrated peptides were then separated on a 75-m ID  15 cm
C18 reversed phase cHiPLC column (SCIEX). Solvent A was 0.1%
formic acid in water. Solvent B was 80% acetonitrile containing 0.1%
formic acid and water. The flow rate was set to 300 nL/min. The
following gradient was used: 0–30 min, 2–30% B; 30–35 min, 30–
90% B; hold at 90% B for 10 min, and equilibrate at 2% B for 15 min
prior to next run. For protein identification, obtained MS spectra were
searched by the ProteinPilot database ver.4.0 (SCIEX) using the fol-
lowing parameters: cys alkylation, acrylamide; digestion, trypsin;
processing parameters, biological modification; and search effort,
through ID.
For global proteome analysis, the protein concentration of all sam-
ples for data directed acquisition (DDA) was determined using a
NanoDrop™ spectrophotometer. All samples were diluted appropri-
ately in 25 mM ammonium bicarbonate for each digest volume of 50
l to contain 25 g protein. Samples were treated with RapiGest™ at
80 °C for 10 min and proteins were reduced with 3 mM DTT at 60 °C
for 10m, alkylated with 9 mM IAA at room temperature in the dark and
digested with a 50:1 ratio to Trypsin Gold (Promega). Digestion was
overnight at 37 °C. The resulting digest was acidified with 1% (v/v)
final concentration of trifluoracetic acid for 45 min followed by cen-
trifugation at 16,000 x g for 30min. Peptides were analyzed on a
Thermo QExactive HF using a one hour gradient. The resulting raw
files were processed using Progenesis (ver 3.0) and searched using
Mascot (ver 2.6) against a database containing the 75 QconCAT
sequences (provided as supplementary Data File D1) included in the
synthesis with fixed acrylamide modification of cysteine residues,
variable Met oxidation, and for labeled samples, variable labeling with
[13C6,
15N4]Arg and [
13C6,
15N2]Lys. Label free quantitative values were
obtained from MS1 signal intensities summed for all unique peptides.
Absolute Quantitation of QconCATs—A variant of Glu-fibrinopep-
tide (FP) (GVNDNEEGFFSAR), released from the C terminus of the
QconCATs by trypsin, was used for the absolute quantification of
synthesized QconCATs using MS. Synthetic unlabeled FP (Sigma-
Aldrich, St. Louis, MO), which was quantified by amino acid analysis,
was used as an internal standard. The QconCAT sample dissolved in
0.1% (w/v) RapiGest surfactant (Waters, Milford, MA) was subjected
to trypsin digestion after adding internal standard. After digestion at
37 °C for overnight, samples were mixed with an equal volume of 1%
(v/v) trifluoracetic acid and incubated at 37 °C for 10 min. After
centrifugation at 18,000 g for 3 min, the supernatant was subjected
to STAGE tip purification. The FP present in the purified peptide
sample was measured by SRM. The amount of synthesized QconCAT
was estimated based on the peak area ratios of the heavy and the
light (unlabeled internal standard) forms of FP.
RESULTS
Cell free synthesis can be initiated with either amplified PCR
products or plasmid “mini-preps” with no effect on yield of
output. Either a linear PCR product or circular plasmid DNA is
first used to direct synthesis of the appropriate RNA, synthe-
sized by an SP6 RNA polymerase. The RNA contains an E01
translation enhancer sequence. DNA templates were obtained
by amplification of the QconCAT sequence from the existing
plasmids by PCR, followed by a second, “split primer” PCR
reaction to create QconCATs preceded by the SP6 and E01
sequences. These PCR products were then used as the tem-
plate in the transcription reaction. The overall workflow is
described in Fig. 1.
WGCFS Can Rescue QconCATs That Do Not Express In
Vivo—From the QconCAT series developed for large-scale
quantification of the Saccharomyces cerevisiae proteome (11,
13), we first selected a subset of 11 QconCAT genes that had
failed to express in E. coli along with one well expressed
QconCAT (Protein sequences are presented in supplementary
Data File D1). After subcloning the QconCAT genes into a
plasmid vector optimized for WGCFS, a set of small-scale
synthesis reactions (240 l) was conducted. On SDS-PAGE of
the total WGCFS reaction mixture, all QconCATs were detect-
able as the strongest band at the expected mobility on the
Coomassie-stained image (Fig. 2A prepurification; Fig. 2B,
postpurification), clearly visible above the WGCFS back-
ground. After trypsin digestion and analysis by liquid chroma-
tography-mass spectrometry (LC-MS), all but five of 556 tryp-
tic Q-peptides were detectable by tandemmass spectrometry
(supplemental Fig. S2). In all instances, N and C-terminal
peptides were detectable, additional evidence for expression
of full-length QconCATs. The total synthesis, assessed by a
common quantification tag (GVNDNEEGFFSAR), was of the
order of low tens of micrograms (23  6 g, n  12) or 317 
69 pmol (mean S.D., n 12, Fig. 2C, supplemental Fig. S3).
The yield was thus sufficiently high to support hundreds or
thousands of selected reaction monitoring (SRM) assays,
each of which would typically require 0.1 to 10 fmol “on
column” in a typical LC-MS/MS experiment. Further, the iso-
topic labeling efficiency of synthesized QconCATs was ex-
tremely high, averaging 99.6% (Fig. 2D, supplemental Table
S1). This is more labeling than obtained during expression in
vivo in E. coli, presumably because there was no biosynthesis
of unlabeled amino acid to reduce the relative isotope abun-
dance of the precursor. More extensive labeling extends the
dynamic range for quantification as it reduces the contami-
nation of the “light” channel by unlabeled material from the
partially labeled “heavy” peptide. Particularly noteworthy was
the ability of WGCFS to express high levels of every QconCAT
that had failed to express in E. coli. Expression in vitro pre-
cludes issues of cytotoxicity and it is highly probable that all
QconCATs will be readily expressed in future, further enhanc-
ing the efficiency of generation of these standards.
WGCFS Can Reduce Proteolytic Damage to QconCATs—
When expressed in E. coli, QconCATs are predominantly ex-
pressed in insoluble form and accumulate in inclusion bodies,
which protects them from intracellular degradation. However,
on occasion, we have noted that a purified QconCAT has
undergone marked proteolytic damage, which would make it
difficult to use in a quantitative analysis. One of the features of
the WGCFS is the low level of endogenous proteases result-
ing from the thorough removal of endosperm components
(17), reducing the chance of degradation. We therefore ex-
pressed, in the WGCFS, a QconCAT that was known to un-
dergo proteolysis in E. coli. High yields of this protein were
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obtained, and the protein was intact and of the predicted
mobility on SDS-PAGE, with no evidence of degradation (Fig.
3). The wheat germ system is likely to be able to protect
QconCATs from proteolytic degradation which, even if only
partial, could compromise the stoichiometric equivalence of
each standard peptide embedded within the concatamer.
WGCFS Allows Coexpression of Multiple QconCATs—Pro-
tein synthesis in vitro, more flexible than protein synthesis in
vivo, can allow simultaneous translation of multiple genes in a
single reaction (23–27). It follows that multiple QconCATs
could be coexpressed in a single lysate, opening the possi-
bility of an efficient route to highly multiplexed, absolute quan-
tification of proteomes, bringing closer global proteome quan-
tification. We therefore conducted a cosynthesis experiment
of the same 12 QconCATs (Fig. 4A), each of which was
capable of being synthesized in independent reactions (as
described in Fig. 1). The cosynthesis mixture of QconCATs
was expressed in the absence of stable isotope labels, and at
the end of the reaction the production of each QconCAT was
evaluated by SRM using accurately quantified, equivalent
QconCATs, synthesized independently with stable isotope
labeled lysine and arginine in the reaction mixture (Fig. 4B).
Comparison of the “light” (cosynthesis) and “heavy” (inde-
pendent synthesis) channels would therefore indicate the im-
pact of coexpression on the yield of all or individual Qcon-
CATs (Fig. 4C). Despite the complexity of the synthesis
mixture, all 12 QconCATs were expressed simultaneously in a
single WGCFS reaction (Fig. 4B, 4C). The yield of each Qcon-
CAT matched or exceeded that of the independently synthe-
sized proteins (Fig. 4C, supplemental Fig. S4). Thus, all Qcon-
FIG. 1. Overall experimental design for QconCAT expression in a cell-free system. Existing QconCAT genes, cloned into pET-21a, were
recovered by a two stage PCR process to create PCR products that contained both the SP6 promoter and the E01 translation enhancer (panel
A). The PCR products were then used to first direct RNA synthesis in vitro, and the transcripts were used without purification in the cell-free
translation reaction, initially in 240 l synthesis reactions in a 96 well plate (panel B). The yield of each stable isotope labeled QconCAT was
measured by mass spectrometry, making use of the common glu-fibrinopeptide contained in each QconCAT and accurately quantified
unlabeled glu-fibrinopeptide as a standard (panel 1C).
FIG. 2. Expression in vitro of multiple QconCATs. Twelve QconCAT genes, eleven of which had failed to express in vivo were selected.
The coding regions was recovered by selective PCR amplification (panel A) and were expressed in vitro by cell-free synthesis in the presence
of [13C6][
15N4]arginine and [
13C6][
15N2] lysine and purified by a hexahistidine tag (panel B). The QconCATs were quantified by selected reaction
monitoring using Glu-fibrinopeptide as standard (panel C), indicating typical yields of 250 pmol per reaction. Labeling of peptides was
extremely efficient (panel D).
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CATs were synthesized at least as well or better than
individual proteins. A single reaction mixture of 240 l, deliv-
erable in less than 2 days, was therefore capable of support-
ing the synthesis of 12 QconCATs at a yield of 37  12 pmol
(mean  S.D., n  12, range 21 to 53 pmol) permitting
hundreds of assays for the quantification of (in this example)
253 target proteins at a redundancy level of two Q-peptides
for each target protein. Although the yield of each QconCAT in
the cosynthesis reaction on a small scale (240 l) was re-
duced when compared with independent synthesis, this was
anticipated from the design, that delivered the same total DNA
input, but distributed equally over 12 QconCATs (supplemen-
tal Fig. S4). In practice, the yield for most QconCATs was
reduced by a lower degree than anticipated, meaning that the
efficiency of cosynthesis was higher. For convenience, we
refer to this approach of cosynthesis of multiple QconCATs by
the acronym “MEERCAT” (Multiplexed Efficient Expression of
Recombinant QconCATs) for brevity. The decreased output of
each QconCAT in a cosynthesis mixture presumably reflects
competition among the different QconCAT transcripts for ac-
cess to the WGCFS translational apparatus, or depletion of
precursors or ATP. Such limitations are readily addressed by
adjustment of the scale of the biosynthesis.
Independent Quantification of QconCATs Coexpressed in
WGCFS—Coexpression of QconCATs by MEERCAT would
introduce the requirement that each concatamer be quantified
independently, before being deployed in quantitative pro-
teomics experiments. This would require each QconCAT to
FIG. 3. Prevention of proteolysis of
QconCATs in the cell-free expression
system. One QconCAT (GGB1, for quan-
tification of isoforms of major urinary
proteins) was expressed in E. coli. Dur-
ing expression, and after histag purifica-
tion, several low molecular weight
species products were copurified
(“Fragments”) These were demonstrated
to be fragments of GGB1 by in gel di-
gestion and mass spectrometry. When
expressed in the cell-free system, no
proteolytic degradation products were
apparent. The bands in the background
marked with an asterisk were derived
from the cell-free system, further evi-
dence by their appearance in the prod-
ucts of three unrelated, low molecular
weight proteins (highlighted by arrows at
20 kDa).
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contain an independent quantification tag. As proof of con-
cept and to illustrate the feasibility of such an approach, we
created a series of mass-coded tags based on glu-fibrinopep-
tide (EGVNDNEEGFFSAR) lacking the N-terminal glutamic
acid residue (Fig. 5A) by mismatch in the PCR primers. A
series of variants of this peptide, differing by the addition of a
single amino at the amino terminus (R/XEGVNDNEEGFFSAR/,
in which X was one of G, A, V, L, S, T, N, F, Y, W or Q) were
thus introduced to the set of QconCAT sequences at the N
terminus by variation in the PCR primer (Fig. 5B), providing a
mass unique independent tag for each protein. These 12
QconCATs were then expressed in a stable isotope labeled
12-plex reaction mixture. At the same time, a further three
“level 2” QconCATs, encoding all variants of the independent
tags were synthesized in unlabeled form and independently
quantified (Fig. 5C). The 12-plex mixture of tagged QconCATs
was then mixed with a pool of the three “level 2” standard
QconCATs that had been independently quantified using a
second Glu-fibrinopeptide quantification peptide. After codi-
gestion, each of the independent variant tags gave sharp
chromatographic peaks that were distributed, as expected,
over a narrow range of retention times (Fig. 5D) and which
yielded well behaved precursor and product ion spectra.
Thus, independent quantification of each of the 12 products
of the cosynthesis was feasible using a simple mass-coded
tag.
Highly Multiplexed Coexpression of QconCATs—Having
demonstrated that 12 QconCATs (eleven of which had previ-
ously failed to express in E. coli) could be both rescued and
expressed simultaneously in vitro, we then tested the ability of
the system to extend the degree of multiplexing and cosyn-
thesize a very large number of QconCATs simultaneously, in a
single reaction. We therefore attempted the coexpression of a
large number of “typical” 70–75 kDa QconCATs (Fig. 6A). We
used template DNA amplified from 76 QconCAT genes pre-
viously designed for quantification of the S. cerevisiae pro-
teome (13), encoding 4000 standard peptides. First, we
established that the QconCATs could be expressed inde-
pendently in low volume WGCFS experiments (supplemental
Fig. S5). Of the 76, 71 were readily detectable by mass spec-
trometry, the low levels of the reminder we attribute to the
reduced quantity of DNA available for transcript generation for
that construct (see below). Then, all the QconCAT PCR prod-
ucts were mixed in equal volumes to create a pool of tem-
plates to direct multiplexed transcription, followed by cell-free
translation. Using a larger volume for the WGCFS reaction,
the average yield of QconCATs was 8  4 g (mean  S.D.,
n  71, range 1 to 23 g) or an average of 100 pmol of each
QconCAT. Whether assessed by SRM (Fig. 6B) or label free
quantification using DDA (Fig. 6C), there was a strong rela-
tionship between the quantity of QconCATs produced in the
multiplexed cosynthesis and the quantity from independent
synthesis, implying a common factor determining yield. This
might be in part attributed to translational efficiency but there
was a weak correlation between the yield of each QconCAT
and the amount of DNA that was used as template (Fig. 6D).
Normalization of input DNA should be able to redress inequal-
ities of QconCAT expression. The WGCFS clearly has the
capacity for very high level multiplexed production of Qcon-
CATs in quantities appropriate to quantitative proteomics
studies. The limits of the number of genes that can be syn-
thesized simultaneously in WGCFS will be further expandable.
In fact, simultaneous synthesis of 150 small (25kDa) Qcon-
CATs (21) was possible in a 6-ml reaction volume, of which
149 QconCATs expression was confirmed by MS/MS (sup-
plemental Fig. S6). However, because the resources required
for synthesis in the reaction solution are finite, further increase
in cosynthesis number is expected to lead to a decrease in the
expression yield of individual QconCAT. When considering
the use as an internal standard in mass spectrometry, the
optimal number of QconCATs that can be cosynthesized will
be between 50 and 100.
DISCUSSION
Performance and Future Applications of MEERCAT—So-
phisticated systems modeling of biological processes re-
quires accurate, absolute abundances of proteins. These data
are remarkably nontrivial to acquire. Moreover, technical ap-
proaches are not consistent in the quantification values that
they generate. The most robust and unbiased method is
based on LC-MS, supported by accurately quantified stand-
ard peptides that are coanalyzed and discriminated by the
mass offset derived from incorporation of stable isotope atom
centers. The largest absolute quantification study completed
to date has been for 1900 proteins in S. cerevisiae using the
QconCAT strategy (13), a program that took several years. In
addition to providing a gold standard of accurately quantified
yeast proteins, this study also revealed the challenges inher-
ent in this approach, including a significant rate of quantitative
discordance between two peptides targeted to a single pro-
tein and the finite, albeit low, rate of failure of QconCAT
expression. For absolute quantification to become more ac-
cessible and broadly feasible, the need for more efficient
synthesis of concatenated standards became evident during
this study.
FIG. 4. Multiplexed expression and quantification of QconCATs. Twelve QconCATs were either independently synthesized and labeled
with [13C6][
15N4]arginine and [
13C6][
15N2]lysine or coexpressed in a single cell-free reaction without stable isotope labels (panel A). After both
biosynthetic reactions were completed, the reaction mixtures for the individually synthesized QconCATs (each 240 l) were pooled. This pool
was then mixed with an equal volume of the cosynthesis reaction mixture and the relative yield of each QconCAT was assessed by SRM assays
to permit determination of the heavy:light ratio for each SRM peptide (panels B and C) using two peptides for each QconCAT, described in
supplemental Fig. S4.
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WGCFS showed high expression capability in the synthesis
of artificially designed QconCATs. Because WGCFS does not
require codon optimization, the QconCAT sequence con-
structed for expression in E. coli could also be used un-
changed. This result strongly suggests the possibility that
many QconCAT resources developed so far can be smoothly
FIG. 5. Use of mass encoded tags for quantification of cosynthesized QconCATs. The same twelve QconCATs described in Fig. 1 were
recovered from plasmids by PCR using a series of primers that introduced variants of the N-terminal Glu-fibrinopeptide standardization peptide
(panels A, B). These variant tag QconCATs were coexpressed in the absence of stable isotope labeled amino acids. Three “level 2 QconCATs,
encoding all of the tags, were also constructed, expressed and labeled with [13C6][
15N4]arginine and [
13C6][
15N2]lysine, quantified and mixed
with the unlabeled cosynthesis reaction. The mixture was digested with trypsin and analyzed by SRM (panel C). The variant quantification tags
eluted in a tight group, readily discriminable by mass and permitting independent quantification of each coexpressed QconCAT (panel D).
FIG. 6. Simultaneous coexpression of large numbers of QconCATs. A set of 76 QconCATs were either expressed individually or in a
cosynthesis multiplexed reaction (panel A). The individual QconCAT reaction mixtures were pooled, and the yield of QconCATs was either
assessed by SRM using the Glu-fibrinopeptide standard or by data dependent, label-free quantification (DDA, based on summed MS1 intensity
of unique peptides). The yield of the individual QconCATs was strongly correlated between the two synthetic approaches (panel B, C). The yield
of QconCATs, assessed by SRM analysis of the individually synthesized proteins, was also correlated to the quantity of DNA that was used
to drive cell-free expression (panel D).
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transferred to WGCFS. In this study, the cell-free synthesis of
QconCAT was performed using the bilayer reaction method
(22). This method enables high-efficiency translation reaction
for 24 h by separating the substrate layer and the translation
layer. In addition, highly efficient incorporation (99%) of
stable isotope into synthetic proteins can be easily achieved
by adding stable isotope-labeled amino acids of 20 mM to
the translation reaction layer (20). We have demonstrated that
the independent synthesis or cosynthesis reaction by the
bilayer method could provide sufficient yield of stable iso-
tope-labeled QconCATs for MS analysis within 20–24 h (Figs.
2, 4). A further increase in yield is obtained by the introduction
of a dialysis method which allows continuous reaction, but in
most cases, it will be unnecessary. Therefore, we concluded
that low cost and simple bilayer system is appropriate for
MEERCAT. The synthesis reaction on a small scale of several
hundred microliters can reduce the amount of expensive sta-
ble isotope-labeled amino acids to be added while ensuring
sufficient QconCAT synthesis amount for mass spectrometry,
which greatly contributes to a cost reduction of standard
synthesis for absolute quantification. If PCR-based template
construction was performed instead of time-consuming sub-
cloning, one experimenter could fully synthesize more than 50
QconCATs during 2 days, as demonstrated here.
We have demonstrated the simultaneous biosynthesis of
large numbers of QconCATs, an approach that greatly en-
hances the opportunities for large scale absolute proteome
quantification. Coexpression of recombinant proteins in living
cells tends to elicit extreme bias in their expression levels (24).
On the other hand, in a cell-free synthetic system, cosynthesis
reaction with relatively little bias is possible (24, 25), and it is
easy to scale up the number of genes used for coexpression
(27). In this study, we have succeeded in creating the largest
scale cell-free cosynthesis reaction to date and obtain suffi-
cient expression level for MS analysis. Interestingly, there was
no bias in the expression level of each QconCAT in the co-
synthesis reaction as compared with independent synthesis
(Fig. 4). In the cell-free synthesis system of E. coli, homoge-
nization of expression level can be obtained by retaining
identical 5 terminal sequences in each gene (25). Because
QconCATs used this study have a consensus sequence at the
N terminus, there is a high possibility that the same effect was
obtained even in WGCFS. Introduction of a cosynthesis strat-
egy can achieve significant reduction in the cost and feasibil-
ity of preparation of internal standards. Ten WGCSF reac-
tions, each coexpressing 100 QconCATs could realize the
simultaneous synthesis of 1000 QconCATs. At a typical size
of 50 Q-peptides per QconCAT, and a quantification ratio of
two peptides per target analyte protein, this would yield a
resource for quantification of 25,000 proteins, enough to
cover the human proteome. These 10 reactions could be
conducted in parallel in 2 to 3 days, starting from a panel of
plasmid DNA. Because the SP6 transcription reaction can use
PCR products or plasmid DNA as template, the route to
delivery of large quantities of templates, through plasmid
“minipreps,” and hence transcripts, is straightforward. In fu-
ture designs, the SP6 and E01 sequences would be engi-
neered into the initial DNA constructs, or obtained from a
suitable plasmid, such as pEU-01, that contains both leader
sequences within the plasmid. Thus, a panel of QconCAT plas-
mids would be readily propagated and distributed. This would
be a remarkable gain in the delivery of stable isotope standards
and renders other approaches (individual QconCATs, PSAQs
and AQUA peptides) slow and expensive by comparison.
There remains the challenge of obtaining accurate quanti-
fication of each QconCAT in the reaction mixture. We have
demonstrated that it is feasible to create subtly variant quan-
tification tags by single amino acid modifications of a stand-
ard peptide. The same tags can of course be re-used, be-
cause there is no feasible route to the simultaneous absolute
quantification of an entire proteome in a single LC-MS anal-
ysis - repeated analyses using the same sets of QconCATs
would be necessary. As an alternative to development of a
panel of mass-coded tags, equally feasible would be the
hierarchical quantification approach (28), in which unlabeled
QconCATs, containing one peptide from each QconCAT in
the WGCFS cosynthesis, would be prepared in a separate
reaction in unlabeled form. However, this approach precludes
simultaneous quantification of standard and biological ana-
lyte, and there is undoubtedly scope for development of a
series of novel peptides that would allow both standard and
biological analyte to be quantified in the same reaction. We
would thus propose a more robust approach based on use
second order “level 2” QconCATs, similar to the approach
we adopted with the 12-plex reaction (supplemental Fig. S7).
We propose construction of 10 distinct and re-useable tag
sequences (1–10), each of which further encodes modest
amino acid variation (A-J, 10 variant positions per peptide).
Each QconCAT would contain then contain a single tag, and
allow encoding of 100 proteins for quantification. Thus, the
first peptide would be encoded with Tag1A. The second
QconCAT would be differentially identifiably by Tag1B, the
11th QconCAT would be encoded by Tag2A, the 12th Qcon-
CAT by Tag2B, the 100th QconCAT by Tag10J. For quantifi-
cation, we would then express and accurately quantify sec-
ond order QconCATs, optimized for rapid and effective
proteolysis and including all 100 Tags. Moreover, careful anal-
ysis of the relative signal intensities of the tags, optimally
selected from 16 amino acids, would permit a cross check of
expression from the relative intensities in a preliminary MS
analysis, allowing rapid progression to true quantification ex-
periments. For smaller projects, it might be more efficient to
continue with WGCFS expression of individual QconCATs,
followed by purification, independent quantification and pool-
ing for downstream biological projects.
It is reasonable to explore the relative cost of traditional
QconCAT biosynthesis with the MEERCAT, starting in each
instance with the synthesized DNA. For a single QconCAT,
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transformation, colony picking, growth, expression and puri-
fication of the QconCAT would take 9 days. By contrast,
WGCFS production of the QconCAT (transcription, translation
and QconCAT purification would be completed in 3 days.
However, the gains are even more apparent when comparing
expression of 12 QconCATs, for example. The cost of the
DNA is similar, but for MEERCAT, all plasmids can be tran-
scribed and translated in the same reaction, and the overall
time is no different to that for a single QconCAT. For individual
bacterial QconCAT expression, it is likely that no more than 6
QconCATs could be processed simultaneously, and thus, the
time required for expression is substantially greater (approx-
imately twenty days compared with 3 days, a 7-fold saving in
staff time). We have also calculated the relative reagent costs
for the two approaches. A single QconCAT prepared by
bacterial expression would cost twice as much as a single
MEERCAT reaction and both scale linearly with the number of
QconCATs. A major difference between the two approaches
is the final yield of purified standard; the cell culture method
can yield 1–5 mg of QconCAT, but, as reported here, a low
volume MEERCAT reaction yields 25 g of QconCAT. We do
not consider that this is major limitation, as the lower quantity
would still be adequate for hundreds of quantification analy-
ses. Standards that would be used regularly could be readily
expressed by MEERCAT in larger volumes, although the cost
would rise proportionately with the larger volume of the
WGCFS. Ultimately, any increase in cost of MEERCAT would
be more than compensated by the 7-fold saving in staff
time, however. The relative workflows, starting from available
DNA, are summarized in supplemental Fig. S8.
The remarkable jump in efficiency gained by this approach
could transform global quantitative proteomics. To be able to
generate a complete series of standards that could be pre-
pared locally, in adequate quantities and suitable for SRM,
SWATH or PRM analyses would obviate the need for molec-
ular biology skills in proteomics labs, and would be highly
efficient. Quantification kits could also be developed to target
specific pathways or panels of biomarkers. A higher Q-pep-
tide:target protein ratio could quantify post-translational vari-
ants by quantifying total protein and subtraction of the un-
modified fraction defined by a second PTM-targeted site (29).
Further gains in efficiency will derive from the avoidance of
failed QconCATs expressed in vivo and the reduction of risk of
proteolytic damage post expression. In QconCATs, the Q-
peptides that are used do not have to be contiguous in the
target protein. This might alter the primary sequence hydrol-
ysis rate of the standard and analyte, but quantification reac-
tions should be stoichiometrically matched (taking both reac-
tions to completion) rather than kinetically matched (assuming
identical rates of hydrolysis). The rates of hydrolysis can be
equalized by inclusion of interspersed sequences that mimic
the natural primary sequence context (as in (15)). There is an
inherent risk in adopting a “kinetic model” and assuming that
a concatenated standard and the native protein would exhibit
the same digestion kinetics, even if the primary sequence
context is identical. This applies to AQUA and PSAQ quanti-
fication as much as QconCAT; because it cannot be assumed
that analyte and standard will be digested at the same rate, it
is necessary for both reactions to proceed to completion. For
a highly multiplexed MEERCAT reaction, it is likely that there
would need to be some control over the quantity of each
QconCAT that was to be synthesized, to better match the
natural dynamic range of the target proteins. This can be
achieved by adjustment of the DNA in the transcription step,
rather than subsequent manipulation of the transcript that is
more prone to degradation. Alternatively, different QconCATs
could be coexpressed and pooled in an abundance matching
strategy (see below).
A second factor in proteome quantification relates to the
analytical load of large scale quantification experiments using
these different approaches. With data independent acquisi-
tion methods, or fast triple quadrupole instruments, it is pos-
sible to complete the absolute quantification of many hun-
dreds of proteins in single LC-MS/MS runs. The analysis
would therefore include standards for the same number of
proteins. At the high levels of multiplexing offered by Qcon-
CAT based approaches, 10 QconCATs mapping 250 proteins
would introduce about 500 analyte peptides, which, in a com-
plex, cell-derived protein samples, would comprise at least
50,000 measurable, high abundance analyte peptides. By
contrast, the addition of 250 intact protein standards would
expand the peptide pool by perhaps 6000 peptides, creating
a substantial additional load on the duty cycle of modern
mass spectrometers. Thus, a MEERCAT approach would cre-
ate much less of a load on the analytical capacity of the
LC-MS/MS system.
A “Human MEERCAT” Project—How would a MEERCAT
library be established for quantification of, for example, the
human proteome? Setting a target of over 25,000 proteins/
variants, it is perfectly feasible to contemplate the design of a
12 by 96 panel of QconCATs (Fig. 7). These would be avail-
able as plasmids that are readily propagated and distributed
to any interested laboratory. Template DNA could then be
amplified from the plasmid to drive transcription, or transcrip-
tion could be driven directly using the plasmid as a template.
Most usefully, the delivery of the plasmids could be driven by
experimental design, such that individual laboratories would
be able to request a coexpression reaction mixture to create
an entire set of Q-peptides for their system. In total this panel,
comprising 1152 plasmids, would encode 56,000 peptides,
and thus, at a ratio of two peptides per target protein, would
permit the absolute quantification of the entire human pro-
teome. Even in the absence of robotic support, the synthesis
of the entire panel of peptides could be complete within a
matter of days, a phenomenal gain over the traditional route of
construction of QconCATs or any other type of standard.
Although construction of this resource would be technically
straightforward, a significant issue is that of peptide selection.
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In the quantification of S. cerevisiae proteins, we adopted two
peptides per protein as a compromise between cost and
analytical rigour. This allowed us to address the frequency
with which two peptides disagreed—for those proteins for
which we obtained two quantification values from two sibling
peptides, the median log2 ratio between the two peptides was
0.54 and 70% of all sibling pairs yielded quantification values
that were within a 2-fold difference (13). Selection of suitable
Q-peptides can be directed by some obvious filters like those
used previously (30). Ease of excision of each Q-peptide from
the standard or the natural protein is a key factor that switches
quantification from being stoichiometrically driven to being
kinetically driven. Even if the Q-peptide and natural cognate
are retained within the same primary sequence context (15),
some sequences would be slow to digest, and these should
be avoided. In addition, peptides containing amino acids
prone to ectopic modification, such as methionine residues,
should be excluded, as the signal splitting between the oxi-
dized and nonoxidized variants of the peptides not only re-
duces sensitivity but is also unpredictable. Lastly, peptides
should be selected based on their chromatographic behavior
(narrow elution profile, retained by the stationary phases that
are used routinely) and mass spectrometric behavior (clean
and intense precursor ions, generation of consistent and high
intensity fragment ions). It is intuitively obvious that peptides
harboring known post-translational modifications should be
avoided, as these can compromise quantification. It may also
be possible to capitalize on the wealth of peptide data that is
present in ProteomeExchange (31), GPM (32), PASSEL with
Peptide Atlas (33) and SRMAtlas (34). The last, for example,
contains over 158,000 SRM transitions that would inform
QconCAT design. Similarly, the Proteome Tools project has
already synthesized over one third of a million tryptic pep-
tides, with a target of one million (35). In both instances, the
peptides are proteotypic (unique to specific proteins) and
further work would be required to discover which of these are
quantotypic. Lastly, it may be increasingly possible to use
such resources to develop predictive algorithms that assess
optimal candidate peptides for quantification. However, it has
rarely been formally established that such peptide data (ob-
served or predicted) refer to true quantotypic peptides that
can be used as surrogates for quantification. This may require
a higher level of refinement as the resource is developed.
A final decision that must precede a “human MEERCAT”
project relates to the strategy for clustering target proteins
within QconCATs. There are two very different strategies. The
first is based on an abundance clustering, such that proteins
targeted by a QconCAT have similar biological expression
levels. This raises the possibility of quantification in a single
LC-MS/MS run, as standards and analytes would yield similar
signals. However, for the S. cerevisiae project, QconCATs
were designed to map specific pathways, reasoning that this
clustering would be of greater value to other investigators. In
this instance, subgroups of QconCATs targeting any pathway
or functional class could be clustered by abundances, but it is
more likely that repeated runs would be needed to titrate each
standard and analyte signal such that they were within two or
three orders of magnitude of each other. This consideration is
driven in part by the dynamic range performance of the mass
spectrometer being used, but also by the intensity of the
“light” signal derived from the “heavy” QconCAT; as de-
FIG. 7. A strategy for a human MEERCAT project. A library of
1100 QconCAT template DNAs could be assembled in just 12
96-well microplates. In principle, the DNA template in each plate
could then be pooled (adjusting DNA to alter the relative abundance
of each QconCAT if required), transcribed and translated in a single
12-well microplate. One the QconCATs have been designed and
synthesized, the entire set of QconCATs, independently tagged for
quantification, could be prepared in a few days. At a typical QconCAT
size of 50 peptides, this would yield a resource of over 57,000
quantified peptides, covering nearly 30,000 proteins; more than ad-
equate to cover the entire human proteome.
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scribed above, synthesis in vitro allows better labeling than
expression in vivo.
Using a model such as we describe here (Fig. 7), the syn-
thesis of 1152 (12  96) QconCAT plasmids could be readily
achieved for around £300,000 (less than $400,000), using
current commercial rates for DNA synthesis. This is less than
the cost of a single, high grade, LC-MS/MS system suitable
for peptide quantification. Further, we could anticipate addi-
tional and substantial economies of scale for a complete
human (or other) MEERCAT project. These plasmids are es-
sentially an infinite resource, readily shared and propagated,
either selectively or as an entire library, an advantage over
synthetic peptide libraries (35). Each recipient laboratory
would then be responsible for transcription and translation
reactions, an approach that can also offer flexibility in terms of
scale (few groups would require milligram quantities of each
QconCAT) and labeling strategy. The WGCFS system is com-
mercially available, and can be readily deployed by any rea-
sonably well-equipped laboratory. The removal of any re-
quirement for bacterial growth and the speed with which the
WGCFS system can be completed also introduces technical
and speed advantages.
As a final consideration, we advocate the WGCFS system
as a system that is perfectly suited to exploratory studies
using “designer proteins” for proteomics research. The ease
of delivery of adequate quantities of labeled protein allows for
cycles of exploration and refinement. Other concatamers have
been developed for standardization of chromatography elution
(36) and as hybrid standards for quantification of proteins by
mass spectrometry and quantitative Western blotting (37). As
more complex designs are conceived, it is increasingly attrac-
tive to be able to express such proteins free from issues of
cellular toxicity/failure to express and proteolytic degradation.
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